Golden Metal Resources plc announced an update for the Company's 100% owned Garfield project located within the prolific Walker Lane Mineral Belt in Nevada, USA ("Garfield" or the "Project"). Staking Highlights: Garfield Project coverage area increased by 3.68km2 (909 acres) to 9.18km2 (2,268 acres) through United States Bureau of Land Management ("BLM") Mining Claim ("Claim") staking. Additional 44 Claims constitute a 67% increase in the overall Project size and cover additional copper anomalies.

Staking undertaken to address the growing evidence that a buried copper porphyry system may exist at Garfield, and to secure the ground given the exploration rush occurring within the western Unites States in the search for new copper porphyry discoveries. Recently staked ground covers an additional magnetic geophysical high target which was partially imaged during the previously completed ground magnetic survey, as well as a combined total of 25 historical datapoints (from United States Geological Survey and University of Nevada, Reno), including historical mine shafts, prospect pits, and adits, most of which are classified as copper +- gold +- silver +- uranium targets. Field prospecting of the newly acquired ground has confirmed the potential for extensive copper mineralisation across a wide area based on outcropping visual copper mineralisation.

Eight confirmatory rock samples have been submitted to ALS Laboratories in Reno, for assay testing. Next steps: The Company continues to finalise the follow up exploration plans for Garfield which will be announced in due course. En largered Garfield Project showing the location of the two potential porphyry targets located at the Power-Line Zone ('PPL' anomaly) and the High-Grade Zone ('PN' & 'PS' coalescing anomalies) over the Total Magnetic Intensity ground geophysics survey results.

Newly acquired ground is shaded red with the historical copper (plus gold, silver, and/or uranium) occurrences shown as white crosses. Orange circles show the location of recently collected samples which are undergoing assay testing. Location of Figure 2 Cross-Section shown as line A-A'.